Sub‐lingual Immunotherapy: World Allergy Organization Position Paper 2009

@article{Canonica2009SublingualIW,
  title={Sub‐lingual Immunotherapy: World Allergy Organization Position Paper 2009},
  author={Giorgio Walter Canonica and Jean Bousquet and Thomas B. Casale and Richard F. Lockey and Carlos E. Baena-Cagnani and Ruby Pawankar and Paul Charles Potter and Philippe Jean Bousquet and Linda S. Cox and Stephen R. Durham and Harold S. Nelson and Giovanni Passalacqua and Dermot Ryan and Jan L. Brożek and Enrico Compalati and Ronald Dahl and Luis Delgado and Roy Gerth van Wijk and Richard G. Gower and Dennis K. Ledford and Nelson Rosario Filho and Erkka J Valovirta and Osman M. Yusuf and Torsten Zuberbier and Wahiduzzaman Akhanda and Ra{\'u}l L{\'a}zaro Castro Almarales and Ignacio J. Ansotegui and Floriano Bonifazi and Johan Ceuppens and Tom{\'a}s Chivato and Darina Dimova and Diana Mihaela Dumitrascu and Luigi Fontana and Constance H Katelaris and Ranbir Kaulsay and Piotr Kuna and D{\'e}sir{\'e}e E Larenas-Linnemann and Manolis Manoussakis and Krist{\'o}f N{\'e}k{\'a}m and Carlos Nunes and Robyn E. O’Hehir and Jos{\'e} Mar{\'i}a Olagu{\'i}bel and Nerin Bahceciler Onder and Jung Won Park and Alfred Priftanji and Robert Puy and Luis Sarmiento and Glenis K. Scadding and Peter Schmid‐Grendelmeier and Ester Seberov{\'a} and Revaz Sepiashvili and Dirceu Sol{\'e} and Alkis G. Togias and Carlo Tomino and Elina M Toskala and Hugo Van Beever and Stefan Vieths},
  journal={Allergy},
  year={2009},
  volume={64}
}
Co-Authors: Wahiduzzaman Akhanda, Raul Castro Almarales, Ignacio Ansotegui, Floriano Bonifazi, Jan Ceuppens, Tomás Chivato, Darina Dimova, Diana Dumitrascu, Luigi Fontana, Constance HKatelaris, Ranbir Kaulsay, Piotr Kuna, Dèsirée Larenas-Linnemann, Manolis Manoussakis, Kristof Nekam, Carlos Nunes, Robyn O’Hehir, José M Olaguibel, Nerin Bahceciler Onder, JungWon Park, Alfred Priftanji, Robert Puy, Luis Sarmiento, Glenis Scadding, Peter Schmid-Grendelmeier, Ester Seberova, Revaz Sepiashvili… Expand
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA‐GA2LEN statement
TLDR
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA‐GA2LEN statement is described. Expand
Practical guide to skin prick tests in allergy to aeroallergens
TLDR
The Practical guide to skin prick tests in allergy to aeroallergens 2012; 67: 18–24 is cited. Expand
Changes in basophil activation during grass‐pollen sublingual immunotherapy do not correlate with clinical efficacy
TLDR
Changes in basophil activation during grass‐pollen sublingual immunotherapy do not correlate with clinical efficacy in Allergy 2011. Expand
EFFECT OF THE ALLERGIC INFLAMMATORY DISEASE IN THE UPPER RESPIRATORY TRACT TO THE COGNITIVE FUNCTIONS AND THE PHYSICAL PERFORMANCE
S ON THE TOPIC OF THE DISSERTATION I. Tokodi Margaréta, Bella Zsolt, Csábi Eszter, Kiricsi Ágnes, Kollár Edit, Rovó László (2014). Az egyszeri allergéndózis (nazális provokáció) hatása a fizikaiExpand
Sublingual immunotherapy not effective in house dust mite–allergic children in primary care
TLDR
Sublingual immunotherapy not effective in house dust mite–allergic children in primary care, Pediatr Allergy Immunol 2011. Expand
Sublingual immunotherapy: A focused allergen immunotherapy practice parameter update.
  • M. Greenhawt, J. Oppenheimer, +17 authors D. Wallace
  • Medicine
  • Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 2017
TLDR
This dissertation aims to provide a history of medical negligence in the United States from 1989 to 2002, a period chosen in order to explore its roots as well as specific cases up to and including the year in which descriptions of “modern medicine” began to circulate. Expand
Allergen Specific Immunotherapy for Allergic Rhinitis
TLDR
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Expand
Clinical Implications and Facts About Allergic Rhinitis (AR) in Children
Zorica Zivkovic1,2, Sofija Cerovic2, Ivana Djuric-Filipovic1, Zoran Vukasinovic3,4, Jasmina Jocic-Stojanovic2 and Aleksandra Bajec-Opancina5 1US Medical School, European University, BelgradeExpand
Sublingual immunotherapy: World Allergy Organization position paper 2013 update
TLDR
“Raising public awareness about sublingual immunotherapy”, as a need for patients, and strategies to increase awareness of allergen immunotherapy (AIT) among patients, the medical community, all healthcare stakeholders, and public opinion are reported in detail. Expand
Sublingual immunotherapy (SLIT)--indications, mechanism, and efficacy: Position paper prepared by the Section of Immunotherapy, Polish Society of Allergy.
TLDR
The highest quality evidence supporting the efficacy of SLIT lasting 1-3 years has been provided by the large scale double-blind, placebo-controlled (DBPC) trials for grass pollen extracts, both in children and adults with allergic rhinitis. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 376 REFERENCES
Local immunotherapy
Mailing H,-J, Abreu-Nogueira J, Alvarez-Cuesta E, Bjorksten B. Bousquet J, Caillot D, Canonica GW, Passalacqua G, Saxonis-Papageorgiou P, Valovirla E. Local immunotherapy. Allergy 1998: 53: 933-944.Expand
Standards for practical allergen‐specific immunotherapy
TLDR
This work aims to provide a systematic review and meta-analyses of the phytochemical properties of the fruit fly coronavirus which has been implicated in the spread of influenza in Europe and Asia. Expand
Sublingual immunotherapy for cow's milk protein allergy: a preliminary report
Vervloet D. Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors. Clin Exp Allergy 2003;33:58–64. 5. Van der Brempt X, Ledent C, Mairesse M. AcceleratedExpand
Sublingual immunotherapy for large local reactions caused by honeybee sting: a double-blind, placebo-controlled trial.
TLDR
Honeybee SLIT significantly reduced the extent of LLRs, and its safety profile was good, suggesting that SLIT in hymenoptera allergy deserves further investigation. Expand
Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients.
TLDR
Results are in good agreement with previous reports on SIT and SLIT with other inhalant allergens (mites, grasses), and suggest the potential use of SLIT for Alternaria allergy, mainly in young patients, when there are concerns about the safety of and compliance with the traditional injective therapy. Expand
Reply to the Letter by Dr Fleming Madsen (EAACI ‘Standards for practical allergen‐specific immunotherapy’)
TLDR
The case presented by Madsen is quite clearly a grade IV reaction, based on the rapid onset of generalized urticaria and the fast decrease in lung function, which is not useful in a grading system, but was introduced to describe the variety of manifestations that anaphylactic shock might present. Expand
The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA²LEN meta‐analysis
TLDR
Investigation of the efficacy of SLIT with house dust mite (HDM) extracts in allergic patients suffering from AR and AA through an updated reassessment of randomized controlled trials suggests that more data are needed, derived from large‐population‐based high quality studies, and corroborated by objective outcomes. Expand
A double‐blind, placebo‐controlled study of immunotherapy with grass‐pollen extract Alutard SQ during a 3–year period with initial rush immunotherapy
TLDR
The efficacy and safety of immunotherapy with grass pollen make it possible to consider this treatment fundamental in patients with asthma and/or monosensitized allergic rhinitis, and there was no relationship between clinical improvement and the range of specific immunoglobulin E values. Expand
Anaphylaxis by latex sublingual immunotherapy
TLDR
In the present communication, a 36-year-old woman with latex allergy, affected by urticaria and asthma challenged by the handling or the exposition to latex articles and treated with SLIT is reported, confirming that rare cases of systemic reactions, sometime severe, have been observed during SLIT. Expand
Sublingual‐swallow immunotherapy (SLIT) in patients with asthma due to house‐dust mites: a double‐blind, placebo‐controlled study
TLDR
SLIT in house‐dust‐mite‐related asthma has a good safety profile and improves respiratory function, bronchial hyperreactivity, and QoL and use of inhaled corticosteroids and β2‐agonists was significantly decreased after 25 months of treatment in both groups. Expand
...
1
2
3
4
5
...